Molecular characterization of Kawasaki disease subgroups using cell-free RNA profiling

C Conor J. Loy (Department of Molecular Biology and Genetics, Cornell University) H Hao Wang (Division of Quantitative Sciences, Department of Oncology Johns Hopkins University School of Medicine Baltimore Maryland USA) J Jihoon Kim C Chisato Shimizu J Joan Lenz E Emma Belcher A Adriana H. Tremoulet J Jane C. Burns (Department of Pediatrics, University of California, San Diego, School of Medicine, La Jolla) I Iwijn De Vlaminck

Abstract

Abstract Kawasaki disease is a pediatric vasculitis and the leading cause of acquired heart disease in children. The heterogeneous clinical presentation of Kawasaki disease complicates diagnosis and treatment, highlighting the need for molecular signatures to stratify patients into subgroups to better understand pathogenesis. We performed plasma cell-free RNA sequencing on samples from 98 patients diagnosed with Kawasaki disease, 86 febrile children (62 viral infection, 24 bacterial infection), and 5 healthy children. The Kawasaki disease patients were previously classified into one of four clinical subgroups using 14 clinical variables. Significant differences were observed in cell-free RNA transcript abundance, pathway enrichment scores, and cell type-of-origin fractions, including differences in hepatocyte injury, mitochondrial dysfunction, platelet activation, and developmental markers. This study demonstrates the utility of cell-free RNA to characterize Kawasaki disease subgroups at a molecular level. Cell-free RNA profiles may be used as biomarkers for Kawasaki disease stratification and offer new insight into the pathogenesis of specific KD phenotypes.

Article Details

Volume / Issue Vol. 15, Issue 1
Published August 14, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (9)

C

Conor J. Loy

Department of Molecular Biology and Genetics, Cornell University

H

Hao Wang

Division of Quantitative Sciences, Department of Oncology Johns Hopkins University School of Medicine Baltimore Maryland USA

J

Jihoon Kim

C

Chisato Shimizu

J

Joan Lenz

E

Emma Belcher

A

Adriana H. Tremoulet

J

Jane C. Burns

Department of Pediatrics, University of California, San Diego, School of Medicine, La Jolla

I

Iwijn De Vlaminck